Trial Details
COMPLETEDBasic Information
| Clinical ID | c987 |
|---|---|
| Identifier | NCT02129439 |
| Trial Title | Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: SB012|DRUG: Placebo |
Participant Information
| Sponsor | Sterna Biologicals GmbH & Co. KG |
|---|---|
| City | Braunschweig |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2025-04-14 |
|---|---|
| Primary Completion Date | 2017-06-22 |
| Completion Date | 2017-06-22 |